MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 6791-6800 Newer>
The Motley Fool
October 18, 2010
Travis Hoium
Lexicon Pharmaceuticals Shares Popped: What You Need to Know Lexicon Pharmaceuticals shares jumped 10% in early trading Monday on unusually high trading. mark for My Articles 30 similar articles
The Motley Fool
October 15, 2010
Brian Richards
Here's How Intuitive Surgical Makes Money A very simple look at the surgical robot maker's business model. mark for My Articles 128 similar articles
The Motley Fool
October 15, 2010
Travis Hoium
Questcor Shares Popped: What You Need to Know Questcor Pharmaceuticals shares jumped 10% early Friday on news the company received Food and Drug Administration approval for H.P. Acthar Gel. mark for My Articles 6 similar articles
The Motley Fool
October 14, 2010
Matt Koppenheffer
Cell Therapeutics' Shares Popped: What You Need to Know Shares of biopharma specialist Cell Therapeutics leapt more than 16% today on huge volume. mark for My Articles 58 similar articles
The Motley Fool
October 14, 2010
Sean Williams
Should You Let AstraZeneca Go? Multiple drug patent expirations await. It's time to run away. mark for My Articles 360 similar articles
The Motley Fool
October 14, 2010
Travis Hoium
ATEC Shares Popped: What You Need to Know Is this meaningful? Or just another movement? mark for My Articles 17 similar articles
The Motley Fool
October 14, 2010
Matt Koppenheffer
Generex Shares Plunged: What You Need to Know Shares of Generex Biotechnology slid more than 10% in intraday trading as investors weighed the upcoming vote on a reverse stock split. mark for My Articles 51 similar articles
The Motley Fool
October 13, 2010
Travis Hoium
Keryx Biopharmaceuticals Shares Popped: What You Need to Know Keryx Biopharmaceuticals Inc. shares jumped 10% in intraday trading today, on over three times the average volume for the last three months. mark for My Articles 86 similar articles
The Motley Fool
October 13, 2010
Seth Jayson
From Gross to Net at Becton Dickinson With recent margins exceeding historical averages, medical device company Becton Dickinson looks like it's doing fine. mark for My Articles 748 similar articles
The Motley Fool
October 13, 2010
Brian Orelli
Don't Get Addicted to Alkermes' Low Revenue Vivitrol's launch and the approval of Bydureon will drive revenue -- and Alkmeres' stock price -- in the future. mark for My Articles 54 similar articles
<Older 6791-6800 Newer>    Return to current articles.